COMMUNIQUÉS West-GlobeNewswire

Immuron to Commence US Non-Deal Institutional Investor Roadshow
19/06/2019
MELBOURNE, Australia, June 19, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the [...]
Momenta Pharmaceuticals Announces Settlement Agreement with Amphastar Resolving Enoxaparin Sodium Injection Litigation
19/06/2019
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
HempAmericana Announces Final Production Machinery and Timing for Initial Commercial Shipments
19/06/2019
NEW YORK, June 19, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging leader in the CBD products market, is excited to announce the purchase and [...]
eSolutions Acquires RCM Software Vendor Practice Insight
19/06/2019
The acquisition demonstrates eSolutions’ continued commitment to invest in core solutions that support its customers and grow its overall capabilities OVERLAND PARK, Kan., June 19, 2019 (GLOBE NEWSWIRE) -- eSolutions, a [...]
Samumed Doses First Subject in Phase 3 STRIDES-X-ray Trial of Lorecivivint for the Treatment of Knee Osteoarthritis
19/06/2019
The study will measure clinical and structural effects to assess the disease-modifying capabilities of lorecivivint SAN DIEGO, June 19, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has dosed the first [...]
Biotricity Doubles Sales Force – Expands Device Fleet by 59%
19/06/2019
REDWOOD CITY, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY ), a medical diagnostic and consumer healthcare technology company, today announced that it has expanded its fleet of Bioflux devices [...]
Major Shareholder Announcement
19/06/2019
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; June 19, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 30 of the Danish Capital Markets Act that [...]
Network Health Expands Relationship with Inovalon
19/06/2019
Leading Health Plan Extends Engagement and Adds CDEaaS™ and NLPaaS™ to Enable Fully Automated Capture and Analysis of Structured and Unstructured Clinical Data at Large Scale BOWIE, Md., June 19, 2019 (GLOBE NEWSWIRE [...]
Akari Therapeutics’ Nomacopan Demonstrates Positive Early Safety and Efficacy in Phase I/II Clinical Study in Moderate-to-Severe Atopic Keraconjunctivitis (AKC)
19/06/2019
Part A of a safety and efficacy study successfully completed with nomacopan eye drops which were well tolerated with no serious adverse events. Improvement in mean composite clinical efficacy score of 35% by Day 14 and [...]
Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia
19/06/2019
~ Application Seeks to Expand Label to Include an Indication and Phase III Data for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia (CABP) ~ ~ PDUFA Date Set for October 24, 2019 ~ MORRISTOWN [...]
Scholar Rock to Present at the 2019 BMO Prescriptions for Success Healthcare Conference
19/06/2019
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
ProMIS Neurosciences Appoints Renowned Parkinson’s Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board
19/06/2019
Internationally recognized leader in neurodegenerative diseases to advise on programs selectively targeting the toxic oligomer TORONTO and CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. ( [...]
CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films
19/06/2019
OXNARD, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth Corporation (TSX: WEED) ( [...]
Arch Biopartners Announces Start of Phase I Human Trial for Metablok
19/06/2019
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has initiated the Phase I human trial for Metablok (“LSALT peptide”), [...]
Myriad Genetics Receives Second Insurance Reimbursement Decision for its BRACAnalysis® Diagnostic System in Japan
19/06/2019
BRACAnalysis Is Now Indicated as a Companion Diagnostic for Lynparza® (olaparib) in Women with Ovarian Cancer SALT LAKE CITY, June 19, 2019 (GLOBE NEWSWIRE) -- Myriad Genetic Laboratories, Inc., a wholly-owned [...]
PLx Pharma on Track for VAZALORE Regulatory Pathway
19/06/2019
HOUSTON, June 19, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent- [...]
Nabriva Therapeutics Submits Type A Meeting Request to FDA for Intravenous CONTEPO™ (fosfomycin) for injection
19/06/2019
DUBLIN, Ireland, June 19, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious [...]
Sorrento Therapeutics Updates Positive Results of Phase 1b Resiniferatoxin (RTX) in Knee Osteoarthritis Pain Trial
19/06/2019
Forty five patients were treated with escalating doses of RTX in the Phase 1b trial to date. Thirty seven patients received RTX and eight patients received saline (pooled as placebo group). Most adverse events [...]
Abeona Therapeutics reçoit la désignation « Fast Track » de la FDA pour la thérapie génique ABO‑202 AAV9 dans la maladie CLN1
19/06/2019
NEW YORK et CLEVELAND, 19 juin 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), chef de file entièrement intégré dans la thérapie génique et cellulaire, a annoncé aujourd'hui que la Food and Drug [...]

Pages